Navigation Links
Bayer Statement on U.S. Food and Drug Administration Advice for Patients: Serious Errors with Certain Blood Glucose Monitoring Test Strips
Date:8/13/2009

TARRYTOWN, N.Y., Aug. 13 /PRNewswire/ -- Since 2006, Bayer Diabetes Care has not distributed test strips that use GDH-PQQ (glucose dehydrogenase pyrroloquinoline quinone) glucose monitoring technology for its blood glucose meters. As referenced in a U.S. Food and Drug Administration Advice for Diabetic Patients and their Caregivers issued today, blood glucose meters that use GDH-PQQ technology may "produce a falsely high (elevated) blood glucose result."

Bayer Diabetes Care is committed to patient safety and has a portfolio of blood glucose meters that all meet the current FDA requirements. The company adheres to and supports the highest standard of quality in its meters and strives to do everything possible by a manufacturer to ensure the accuracy of readings. Bayer Diabetes Care meters are designed to minimize the impact from as many external variants as possible, helping to ensure accuracy of readings. Bayer's BREEZE(R)2 and CONTOUR(R) systems both feature No Coding(TM) technology, and no interference with common substances including the non-glucose sugars maltose and galactose.

For more information on Bayer Diabetes Care blood glucose monitoring systems, visit www.bayerdiabetes.com.


'/>"/>
SOURCE Bayer Diabetes Care
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Bayer HealthCare Announces Recipients of 2009 International Hemophilia Nursing Fellowship
2. Bayer HealthCare Awards $2.5 Million to Advance Hemophilia Research and Improve Patient Care
3. Bayer HealthCare Launches Hemophilia Self-Infusion Training Program
4. Bayer CropScience and Monsanto Sign Cross Licensing Agreement on Herbicide Tolerance Traits in Rapeseed/Canola
5. Bayer Diabetes Care Launches A1CNow(R) SELFCHECK, a New A1C Monitor for At-Home Use
6. Bayer and Onyx Initiate Phase 3 Trial of Nexavar in Non-Small Cell Lung Cancer
7. AUDIO from Medialink, Bayer Healthcare and Onyx Pharmaceuticals: Facts About Hepatitis
8. Bayer to Present Data on Development Compound BAY 73-4506 at 45th Annual Meeting of the American Society of Clinical Oncology
9. Now Available: Bayer Diabetes Cares CONTOUR(R) Meters in Midnight Blue and Orange Burst
10. Bayer CropScience Welcomes New Emergency Services Leader to the Institute Site
11. J&J, Schering-Plough, Novartis, Bayer vie for Top Honors at the Premier OTC / Healthcare Ad Awards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... 2017 , ... “America On The Brink”: the Christian history of the United ... the creation of published author, William Nowers. Captain Nowers and his wife, Millie, ... spent thirty years in the Navy. Following his career as a naval aviator ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San ... using cutting-edge Oventus O2Vent technology. As many as 18 million Americans are ... cessation in breathing. Oral appliances can offer significant relief to about 75 percent ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has developed a ... and regulatory authorities worldwide. From Children’s to Adults 50+, every formula has been ... standard. , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, ...
(Date:10/12/2017)... Bethesda, MD (PRWEB) , ... October 12, 2017 , ... ... Award of Excellence to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s ... 4 – 8. , In honor of Morris F. Collen, a pioneer in the ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... drug delivery system that we intend to develop to enable prevention of a ... lead to severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)... R.I. , Sept. 25, 2017  EpiVax, ... assessment, vaccine design, and immune-engineering today announced the ... on the development of personalized therapeutic cancer vaccines. ... has provided exclusive access to enabling technologies to ... Eng., MBA will lead EpiVax Oncology as Chief ...
(Date:9/19/2017)... , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device company developing ... of targeted tissues, announced three leadership team developments today:   ... ... ... Veteran medical device executive Josh Stopek ...
(Date:9/13/2017)... 13, 2017   OrthoAtlanta has been named the ... Host Committee (AFHC) for the 2018 College Football Playoff (CFP) ... at Mercedes-Benz Stadium in Atlanta, Georgia . ... "I,m In" campaign, participating in many activities leading up to, ... ...
Breaking Medicine Technology: